Azopt Articles
Alcon's income down 22% to $232M in 3rd-qtr
30 October 2006
Alcon granted European approval for Azopt
17 April 2000
Alcon granted European approval for Azopt
14 April 2000
Showing 1-4 of 4 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
